Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
n decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
n decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
181
-
182
Loss of C9orf72 decreases mTOR activation.
Published 2016“…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”
-
183
-
184
Bufalin downregulates SRC–3 and decreases cell viability in TNBC cells.
Published 2015“…<p>(A) Western blot shows that bufalin (100 nM) downregulates SRC–3 protein levels in TNBC cells. …”
-
185
-
186
-
187
-
188
-
189
Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation.
Published 2010“…(Scale bar = 50 µm; DAPI, nuclear staining, blue). (C,D) Quantitative analyses of differentiated aNPCs demonstrate that <i>Fmr1</i> KO aNPCs differentiated into fewer Tuj1+ neurons (C, n = 4; p<0.01) but more GFAP+ astrocytes (D, n = 6, p<0.05). …”
-
190
-
191
-
192
-
193
-
194
Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability.
Published 2015“…MTT cell viability assay:</b> VCaP cells were transfected with siRNA TMPRSS2-ERG III (1, 2), TMPRSS2-ERG IV (1) and siRNA Control at 50 nM concentration and incubated for 72h. Bars represent mean ± SD of 2 independent experiments containing 8 replicates for each condition. …”
-
195
-
196
-
197
Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability.
Published 2015“…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”
-
198
-
199
CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line.
Published 2014“…(F) Increasing concentrations to 50 nM still enhances clonogenic survival of HBEC 30KT, but actually seems to decrease survival in HCC 4017 after 3 Gy radiation. …”
-
200